WIPO Draft Treaty Text On Genetic Resources Joins Folklore, Traditional Knowledge 04/03/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment Country experts this week took up the challenge of doing the groundwork for negotiations towards a treaty on the protection of genetic resources at the World Intellectual Property Organization. Breaking uncharacteristically early on the final day today, the experts’ work delivered a set of options reflecting all points of views for negotiators to work from.
Draft WIPO Instrument On Genetic Resources Shows Lists Of Options 04/03/2011 by Catherine Saez, Intellectual Property Watch 1 Comment A new draft document was issued yesterday by a drafting group of experts at the World Intellectual Property Organization. The drafting group was in charge of cleaning up a text with aspirations to become a draft international instrument on the protection of genetic resources, and added a number of options for a possible treaty.
WTO Talks On Geographical Indications Unable To Achieve Lift-Off 04/03/2011 by Catherine Saez, Intellectual Property Watch 3 Comments World Trade Organization members on Thursday combed through a composite text displaying the different views on a mandated multilateral system of notification and registration of geographical indications on wines and spirits. The composite text was developed last week as the result of several informal meetings. Countries now have clarified their inputs to the document and tried to define what next steps should be taken to refine it, but discussions were difficult, according to participants.
WHO Working Group Gives Guidelines To Fight Bad Medicines; IMPACT In Exile 03/03/2011 by Catherine Saez, Intellectual Property Watch 4 Comments After three days of intense negotiations on the role of the World Health Organization in the fight against low standard or falsified medicines, delegates provided recommendations for the UN agency. A subject of dissent was the relationship between the WHO and its taskforce against counterfeit medicines, with some countries calling for a suspension of the taskforce’s work, though in the end no consensus was found.
Genetics Company Myriad May Shift From Patents To Proprietary Data 03/03/2011 by Catherine Saez, Intellectual Property Watch 4 Comments Myriad Genetics, a United States-based biotechnology company with exclusive patent rights over a key breast cancer diagnostic test in the US, may shift its patent strategy from its inventions to protecting its data in the face of drawn out litigation and upcoming competition, an industry journal has reported.
Patentable Subject Matter, IP Waiver For Health Discussed At WTO 02/03/2011 by Catherine Saez, Intellectual Property Watch 2 Comments Patentable subject matter was discussed this week at the World Trade Organization with entrenched positions, according to sources, and the momentum started in October on ways to improve a public health exception within the WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, appeared to have lost some steam.
Former Senator To Head Motion Picture Association 02/03/2011 by William New, Intellectual Property Watch Leave a Comment The Motion Picture Association of America, the influential US film industry group, has landed a highly regarded former US senator as its next chairman and chief executive officer.
Public Input Sought In Review Of WIPO Technical Assistance 02/03/2011 by Intellectual Property Watch Leave a Comment Public input is being sought this week for an external review of technical assistance provided by the World Intellectual Property Organization (WIPO). For years, questions have been raised over the fairness and appropriateness of the guidance and training provided to developing countries by WIPO provides, the UN agency whose aim is to promote protection of IP rights.
Group Discussion Deepens Over WHO Role In Stopping Poor Quality Medicines 01/03/2011 by Catherine Saez, Intellectual Property Watch Leave a Comment The role of the World Health Organization in the safety, quality and efficacy of medical products is under scrutiny this week by member states and stakeholders. In particular, the focus is on the WHO’s role in the prevention and control of medical products of compromised quality, the organisation’s relationship with the international taskforce against counterfeit products, and the taskforce’s alleged focus on the protection of intellectual property rights rather than on public health issues. In several documents, the WHO tries to explain this fragile role.
Debate Rises Over Elevating Profile Of Genetic Resources At WIPO 01/03/2011 by Catherine Saez, Intellectual Property Watch 1 Comment Experts discussing the protection of genetic resources at the World Intellectual Property Organization this week are struggling to stay within their technical mandate as the issues carry significant political impact. Discussions today resulted in a marked-up text on objectives and principles of a possible international instrument that reveals key differences among members on the role of IP, and of WIPO, in genetic resources.